Atif Mehmood^1,2, Zhonglong Zheng^1,*, Rizwan Khan¹, Ahmad Al Smadi³, Farah Shahid^1,2, Shahid Iqbal⁴, Mutasem K. Alsmadi⁵, Yazeed Yasin Ghadi⁶, Syed Aziz Shah⁸, Mostafa M. Ibrahim⁷

CMC-Computers, Materials & Continua, Vol.80, No.2, pp. 2081-2098, 2024, DOI:10.32604/cmc.2024.046869 - 15 August 2024

Abstract Neuroimaging has emerged over the last few decades as a crucial tool in diagnosing Alzheimer’s disease (AD). Mild cognitive impairment (MCI) is a condition that falls between the spectrum of normal cognitive function and AD. However, previous studies have mainly used handcrafted features to classify MCI, AD, and normal control (NC) individuals. This paper focuses on using gray matter (GM) scans obtained through magnetic resonance imaging (MRI) for the diagnosis of individuals with MCI, AD, and NC. To improve classification performance, we developed two transfer learning strategies with data augmentation (i.e., shear range, rotation, zoom… More >

Yan Huang^1,*, Xiaoye Liao², Fen Cai³

International Journal of Mental Health Promotion, Vol.25, No.12, pp. 1313-1321, 2023, DOI:10.32604/ijmhp.2023.030558 - 29 December 2023

Abstract Background: Elderly people with depression require special care and attention. However, nostalgia is a complex emotional situation for a person who recalls the missing past. To improve mental health, quality of life, and attitudes toward aging in institutional care, group nostalgia therapy can be a nursing intermediary for the elderly. This study aimed to analyze the effect of group nostalgia therapy on quality of life cognitive function in elderly patients with depression. Methods: A total of 89 participants were enrolled in this study, which was further categorized into a control (n = 40) and a… More >

Eun Kyoung Han, Hae Kyoung Son^*

International Journal of Mental Health Promotion, Vol.25, No.11, pp. 1197-1208, 2023, DOI:10.32604/ijmhp.2023.041560 - 08 December 2023

Abstract Dementia prevalence has soared due to population aging. In Mild Cognitive Impairment (MCI) as a pre-dementia stage, sleep disturbances have raised much interest as a factor in a bidirectional relationship with cognitive decline. Thus, this study developed the Sleep and Cognition Enhancement Multimodal Intervention (SCEMI) based on Lazarus’ multimodal approach and conducted a randomized controlled experiment to investigate the effects of the novel program on sleep and cognition in MCI elderly. The participants were 55 MCI elderly with sleep disturbances at two dementia care centers located in S-city, Gyeonggi-do, South Korea (n = 25 in… More >

Deepthi K. Oommen^*, J. Arunnehru

CMC-Computers, Materials & Continua, Vol.76, No.1, pp. 793-811, 2023, DOI:10.32604/cmc.2023.038640 - 08 June 2023

Abstract Alzheimer’s Disease (AD) is a progressive neurological disease. Early diagnosis of this illness using conventional methods is very challenging. Deep Learning (DL) is one of the finest solutions for improving diagnostic procedures’ performance and forecast accuracy. The disease’s widespread distribution and elevated mortality rate demonstrate its significance in the older-onset and younger-onset age groups. In light of research investigations, it is vital to consider age as one of the key criteria when choosing the subjects. The younger subjects are more susceptible to the perishable side than the older onset. The proposed investigation concentrated on the… More >

Meshal Alharbi, Shabana R. Ziyad^*

CMC-Computers, Materials & Continua, Vol.74, No.3, pp. 5483-5505, 2023, DOI:10.32604/cmc.2023.032341 - 28 December 2022

Abstract Aging is a natural process that leads to debility, disease, and dependency. Alzheimer’s disease (AD) causes degeneration of the brain cells leading to cognitive decline and memory loss, as well as dependence on others to fulfill basic daily needs. AD is the major cause of dementia. Computer-aided diagnosis (CADx) tools aid medical practitioners in accurately identifying diseases such as AD in patients. This study aimed to develop a CADx tool for the early detection of AD using the Intelligent Water Drop (IWD) algorithm and the Random Forest (RF) classifier. The IWD algorithm an efficient feature… More >

Zhengtao Xi¹, Chaofan Song², Jiahui Zheng³, Haifeng Shi³, Zhuqing Jiao^1,2,*

CMES-Computer Modeling in Engineering & Sciences, Vol.135, No.3, pp. 2243-2266, 2023, DOI:10.32604/cmes.2023.023544 - 23 November 2022

Abstract The structure and function of brain networks have been altered in patients with end-stage renal disease (ESRD). Manifold regularization (MR) only considers the pairing relationship between two brain regions and cannot represent functional interactions or higher-order relationships between multiple brain regions. To solve this issue, we developed a method to construct a dynamic brain functional network (DBFN) based on dynamic hypergraph MR (DHMR) and applied it to the classification of ESRD associated with mild cognitive impairment (ESRDaMCI). The construction of DBFN with Pearson’s correlation (PC) was transformed into an optimization model. Node convolution and hyperedge convolution… More > Graphic Abstract

Anuj Singh^*, Raman Kumar, Arvind Kumar Tiwari

Computer Systems Science and Engineering, Vol.45, No.1, pp. 513-530, 2023, DOI:10.32604/csse.2023.029608 - 16 August 2022

Abstract Alzheimer’s disease is a non-reversible, non-curable, and progressive neurological disorder that induces the shrinkage and death of a specific neuronal population associated with memory formation and retention. It is a frequently occurring mental illness that occurs in about 60%–80% of cases of dementia. It is usually observed between people in the age group of 60 years and above. Depending upon the severity of symptoms the patients can be categorized in Cognitive Normal (CN), Mild Cognitive Impairment (MCI) and Alzheimer’s Disease (AD). Alzheimer’s disease is the last phase of the disease where the brain is severely… More >

Nora Shoaip¹, Amira Rezk¹, Shaker EL-Sappagh^2,3, Tamer Abuhmed^4,*, Sherif Barakat¹, Mohammed Elmogy⁵

CMC-Computers, Materials & Continua, Vol.69, No.3, pp. 3531-3548, 2021, DOI:10.32604/cmc.2021.019069 - 24 August 2021

Abstract Alzheimer’s disease (AD) is a very complex disease that causes brain failure, then eventually, dementia ensues. It is a global health problem. 99% of clinical trials have failed to limit the progression of this disease. The risks and barriers to detecting AD are huge as pathological events begin decades before appearing clinical symptoms. Therapies for AD are likely to be more helpful if the diagnosis is determined early before the final stage of neurological dysfunction. In this regard, the need becomes more urgent for biomarker-based detection. A key issue in understanding AD is the need… More >